Mutares SE & Co. KGaA’s Post

16 years ago…   we founded Mutares SE & Co. KGaA with a vision to transform simple businesses into sustainable, profitable enterprises. It's been a journey of ups and downs, triumphs and challenges, but giving up was never an option.   There were moments of doubts, sleepless nights, and tough decisions. But with each company we turned around, our resolve only grew stronger.   As I look ahead to our Capital Markets Day on October 24th, 2024, I'm filled with gratitude at how far we've come. From our founding back in 2008, we've grown into a global player in Private Equity, with offices worldwide.   At this upcoming event, we will be presenting on "The Buffalos of European Private Equity." We chose this theme because, like these powerful animals, we at Mutares want to take over responsibility in this challenging economic environment. We don't shy away from the storm - we thrive in it.   Moreover, there will be some insights into our portfolio companies and further engaging talks.   I want to take a moment to express my thanks to our exceptional Management Board: Mark Friedrich, Johannes Laumann, and Lennart Schley, and the entire Mutares team - your hard work, commitment, and resilience are the backbone of our achievements.   As we look to the future, our ambitions are bigger than ever, and we've never been ones to think small.

📣 A New Chapter Begins! Today, we announce that Miura Partners, a firm specializing in investing in small and medium-sized companies with a focus on #innovation and #growth, has become the majority shareholder of the company. This #acquisition aligns with our plans for significant growth in the coming years 📈 This new milestone in HTBA (HealthTech BioActives)’s history marks an important step forward and the consolidation of our growth #strategy, which is based on innovation and #sustainability 🌱 We remain committed to offering #solutions that enhance the health and well-being of both people and animals, as we continue to lead the industry globally 🌍 #innovation #growth #strategy #acquisition #sustainability

🔔🚀 Can you imagine being 𝗮 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝗶𝗻 𝘁𝗵𝗲 𝘁𝗿𝗮𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 sector and selling the business that generates 70% of 𝘆𝗼𝘂𝗿 𝘁𝘂𝗿𝗻𝗼𝘃𝗲𝗿 𝗳𝗼𝗿 𝗮 𝗻𝗲𝘄 𝘃𝗶𝘀𝗶𝗼𝗻? 𝗜𝘁’𝘀 𝘃𝗲𝗿𝘁𝗶𝗴𝗼-𝗶𝗻𝗱𝘂𝗰𝗶𝗻𝗴, isn’t it? 🧨 🧭 Today, I bring you the success story of Uriach, the protagonist in this 𝗱𝗲𝗲𝗽 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 that fascinates me. At the event "𝘾𝙖𝙛è 𝘿𝙞𝙨𝙧𝙪𝙥𝙩𝙞𝙪: 𝙏𝙝𝙚 𝙘𝙖𝙨𝙚 𝙤𝙛 𝙐𝙧𝙞𝙖𝙘𝙝, 𝙤𝙧 𝙝𝙤𝙬 𝙩𝙤 𝙧𝙖𝙙𝙞𝙘𝙖𝙡𝙡𝙮 𝙩𝙧𝙖𝙣𝙨𝙛𝙤𝙧𝙢 𝙮𝙤𝙪𝙧 𝙗𝙪𝙨𝙞𝙣𝙚𝙨𝙨", hosted by ACCIÓ, Oriol Segarra, CEO of the company, shares first-hand how they have undertaken this transformation and the keys to their success. 🏆 In the interview, he was asked about the 𝗯𝗶𝗴𝗴𝗲𝘀𝘁 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 on this transformative journey; his response was unequivocal: «𝗧𝗵𝗲 𝗴𝗿𝗲𝗮𝘁𝗲𝘀𝘁 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝘄𝗮𝘀 𝘁𝗮𝗸𝗶𝗻𝗴 𝘁𝗵𝗮𝘁 𝗱𝗲𝗰𝗶𝘀𝗶𝘃𝗲 𝗳𝗶𝗿𝘀𝘁 𝘀𝘁𝗲𝗽 𝗮𝗻𝗱 𝗮𝗰𝘁𝗶𝗻𝗴 𝗮𝗰𝗰𝗼𝗿𝗱𝗶𝗻𝗴𝗹𝘆 🛤️» Uriach, a Catalan company with more than 185 years of history, has reinvented itself as a leader in the 𝗡𝗮𝘁𝘂𝗿𝗮𝗹 𝗖𝗼𝗻𝘀𝘂𝗺𝗲𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 🌍, focusing on producing, distributing, and marketing natural products committed to sustainability. 🌿🌿🌿 Their 𝗺𝗶𝘀𝘀𝗶𝗼𝗻: to improve the health and well-being of people by combining science and nature under the motto "𝙉𝙖𝙩𝙪𝙧𝙖𝙡 𝙃𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙀𝙣𝙝𝙖𝙣𝙘𝙚𝙙 𝙗𝙮 𝙎𝙘𝙞𝙚𝙣𝙘𝙚" 🌿. This company, 𝗮 𝗿𝗲𝗳𝗲𝗿𝗲𝗻t 𝗶𝗻 𝗶𝘁𝘀 𝘀𝗲𝗰𝘁𝗼𝗿, has shown t𝗵𝗮𝘁 𝗱𝗲𝘁𝗲𝗿𝗺𝗶𝗻𝗮𝘁𝗶𝗼𝗻, 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 action, 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗮𝗹𝗶𝗴𝗻𝗺𝗲𝗻𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗲𝗻𝘁𝗶𝗿𝗲 𝘁𝗲𝗮𝗺 are key to achieving any goal 🎯. 🌐 Highlighting three strategic lines that have boosted their expansion 🌐: 👉 The 𝗮𝗰𝗾𝘂𝗶𝘀𝗶𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 Naturitas. 👉 The entry of a British 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗙𝘂𝗻𝗱 Intermediate Capital Group (ICG) with 30% of the capital (November 2023). 👉 The 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗲𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻 in Europe through acquiring numerous companies in the sector 🚀. ✍️💡 In the carousel, I share fascinating data about Uriach and the keys to its success 💡✍️➡️➡️➡️➡️➡️. Did anything about this 🔝story surprise you? I read your comments below 👇 #transformation #sustainability #leadership #disruption #strategy #blueoceanstrategy #businessmodelinnovation #cafedisruptiu

Sumeet Narang, Founder, Managing Director & co-CIO, recently spoke with ET Now on Samara Capital's journey and our vision for the future. Since our inception in 2007, when Sumeet Narang, Gautam Gode, Paurush Roy, and Manish Mehta came together during the formative years of Samara, we have remained steadfast in our approach as an owner-operator investor with a buyout-focused strategy. Our culture of nurturing talent has enabled leaders like Vikram Agarwal, Anchit Gupta, and Abhishek Kabra to thrive and grow within Samara, while Abhik Mitra, who now leads our Operations Group, returned to the firm after successfully managing the integration of an investee company post its sale to a strategic acquirer. Sumeet emphasized our three-pronged approach, which continues to drive our success: • 𝐑𝐢𝐠𝐨𝐫𝐨𝐮𝐬 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐟𝐮𝐥 research that informs and shapes our investment decisions. • 𝐄𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐧𝐞𝐭𝐰𝐨𝐫𝐤𝐬 that convert research into compelling investment opportunities. • 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐯𝐚𝐥𝐮𝐞 𝐜𝐫𝐞𝐚𝐭𝐢𝐨𝐧 across pre- and post-investment phases. In the consumer sector, we recently spearheaded the Del Monte-Agrotech combination, demonstrating our commitment to roll-up strategies aimed at building sizeable and scalable platforms. Within this initiative, our focus is on identifying brands with pan-India appeal in underpenetrated categories, leveraging our strengths in product innovation, manufacturing excellence, and distribution optimization. As India's private equity landscape evolves, we remain dedicated to our core principles while embracing emerging opportunities that align with our vision. https://lnkd.in/er5dFYgW

Innovation drives growth. Partner with Totalbsa to turn groundbreaking ideas into tangible success. #InnovationInBusiness #Totalbsa #BusinessGrowth #CreativeSolutions #InnovateToElevate

🚀 Slow and steady? That’s the past! It’s time to turbocharge your brand with Vcana Global. Let’s power up together! 💼✨ #BrandGrowth #VcanaGlobal #BusinessSuccess #DigitalTransformation #MarketingSolutions #GrowWithUs #SuccessUnlocked #ThinkBigActFast

Why are business conferences and panels so drab? Well, at least most of the time they are 🤔 Often, panelists 👺 are not relevant, lacking an opinionated point of view,  🤐 don’t invest in understanding the audience, and 💪 are unaware of the strengths of their co-panelists But when these fall into place, it works like an orchestra. The panel organised by Indian Venture and Alternate Capital Association (IVCA) on "The Hot Indian startup - Is IPO the Holy Grail for you" felt like one, according to Manish Kheterpal It helped that IPO markets are on a tear in 🇮🇳, but also because the panelists were well prepared, were complimentary and the panel brought unique practitioners' experiences to the table. This group included a seasoned i-banker CEO for public markets in Sonia Dasgupta from JM Financial; a midas touch consumer, financial services growth investor in Sakshi Chopra from Peak XV; ace private to public spectrum Tech i-banker Karan Sharma from Avendus - all of whom have worked in the industry and with each other over several decades. Manish from WaterBridge Ventures moderated this discussion. A picture says a thousand words - this one shows how fun it was for everyone involved. Audience feedback tells us how insightful it was too. Key questions discussed: 🎠 How can a late-stage private market raise help the going public journey? 🃏 Why should companies stay private for longer (contrarian view given markets today) 💰 How much should VC/PEs sell pre-IPO, as part of OFS, or should they wait it out post-IPO? ✅ What are the traits /characteristics of founding teams and companies that go public and achieve post-IPO success in India? 🤼♂️ How long would the IPO party last for new-age companies in the most prolific IPO market of 2024 (25% of global happened here)? All this with real examples and anecdotes. It helped that the backdrop has new-age Tech market cap far exceeding $100B in India (just in the past 30 months). Great setup, thanks to IVCA, Amit Pandey, Yachna Luthra, Sunitha Prasad and the team for conceptualising this highly topical conference and for bringing the masters of the trade to the stage. Anjali Ashish

Salestorrs, suitors are queuing for Haldiram's. After Blackstone and Bain Capital, now Alpha Wave Global has thrown its hat in the ring. Earlier known as Falcon Edge, Alpha Wave is a Tiger Global Management subsidiary. Haldiram’s Snacks Food is selling 15-20%. One interested group is led by Bain Capital, partnered by Temasek, and the other is led by Blackstone, Singaporean GIC, and Abu Dhabi Investment Authority (ADIA). With the stake sale, Haldiram’s promoter group is hoping to receive the public market premium of ₹93,500 crore ($11 billion), while the family is vying to get at least a $10 billion valuation from the investors, ET reported. Alpha's entry, while surprising at best, also changes the deal dynamics. find out how in today's #SalestorrsNews150, news in 150 words. LINK IN COMMENTS BELOW. #salestorrs #salestors #haldirams #newsinbrief #foodindustry #snacks

2024 has been a year full of exciting achievements, strategic growth, and incredible milestones that inspire us to aim even higher. Here's a look at what we accomplished: ✅ Exported over 3,500 tons of high-quality products to more than 13 countries, expanding our global footprint. 🌍 ✅ Launched an exclusive private label program of bird food 🦜with a top-tier Nordic company, marking a significant step in our international partnerships. 🇳🇴 ✅ Successfully introduced our flagship brands, Vestigio and Feeders Choice, into the dynamic Asian market. 🌏 ✅ Reached an impressive 200% growth in total sales, showcasing the strength of our strategy and team! 📈 As we prepare for 2025, our ambition only grows. We're setting our sights on a bold goal: achieving 250% growth. With a dedicated and passionate team, we are confident this milestone is within reach. Thank you to our partners, clients, and team members for making 2024 unforgettable. Together, we’re shaping a brighter future for PatagonPets! #PatagonPets #GlobalLeadership #PetIndustry #PrivateLabel #Teamwork #AsiaExpansion #NordicMarkets #Vestigio #FeedersChoice #Export #Innovation #2025Goals

2025 is the year of Growth! Eupry Secures $24M Series A funding........ After what has been a turbulent last few years in the cold chain monitoring industry to say the least, its great to see organisations looking to the future and investment partners getting behind their vision. Eupry and their leadership team is a great example of this. By combining the core three compliance industries of validation, monitoring and calibration in their solution strategy Eupry are setting themselves apart from others, digitalising processes across pharma, biotech and logistics, that have in the past been manual and come with its own associated risk. In the recent round Eupry raised $24 Million and welcomed Chr. Augustinus Fabrikker to their current investor team with Ugly Duckling Ventures, Export and Investment Fund of Denmark and Sagitta Family Office in this round. In the article below, Eupry confirm that there main focus from the start has been the reliability and innovation of their product and solution, especially in the highly regulated markets. This just goes to show the organisations that invest time and money back into their teams, products and continuous development are always the ones that will thrive long term. Amazing achievement Christian Jacobsen and all the team at Eupry! I look forward to seeing what comes next! #coldchainmonitoring #temperaturedataloggers #compliance https://lnkd.in/eg99Ehgt